Efficacy of terlipressin therapy for refractory ascites in cirrhosis and type-2 hepatorenal syndrome

Objective To explore the efficacy of terlipressin therapy for refractory ascites in cirrhosis and type-2 hepatorenal syndrome (HRS-2). Methods Forty patients with refractory ascites in cirrhosis and HRS-2 who were admitted to our hospital from June 2009 to June 2014 were randomly divided into treatm...

Full description

Bibliographic Details
Main Authors: ZHAN Guoqing, LI Fang, LI Rugui
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2015-08-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=6811